July 12, 2014 10:08 PM ET

Pharmaceuticals

Company Overview of Afro Alpine Pharma Limited

Company Overview

Afro Alpine Pharma Limited engages in the production and distribution of anti-malarial treatments in Uganda and Africa. The company engages in the cultivation of Artemisia Annua and extraction of drug Artemisinin from its leaves. Its Artemisinin drugs are used for the production of Artemisinin Combination Therapy (ACT), which is used as a treatment for malaria. Afro Alpine Pharma Limited is based in Kabale, Uganda.

P.O.Box 6

Kabale,  

Uganda

Phone:

256 0 486

Fax:

256 0 782 880015

Key Executives for Afro Alpine Pharma Limited

Afro Alpine Pharma Limited does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Afro Alpine Pharma Limited Middle East/Africa
Kampala Pharmaceutical Industries (1996) Ltd. Middle East/Africa
Quality Chemical Industries Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Afro Alpine Pharma Limited, please visit www.afroalpine.co.ug. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.